INSMED INC (INSM)
US4576693075 - Common Stock
These Signs Show Which Stocks Are Having A Hidden Rally, Says Mark Minervini
Meta stock and Insmed stock share characteristics that can help investors look for strong stocks even in weak markets.
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference
/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025
/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference
/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate
Insmed to Host Commercial Webinar on June 4, 2024
/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Insmed Announces Pricing of $650 Million Public Offering of Common Stock
/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Insmed Announces Proposed $500 Million Public Offering of Common Stock
/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Notable Tuesday Option Activity: ANF, INSM, AAP
Insmed Moves Up In Market Cap Rank, Passing Etsy
Why Is P3 Health Partners (PIII) Stock Down 4% Today?
P3 Health Partners stock is down on Tuesday after telling PIII investors about an offering of its shares to institutional investors.
Insmed Catapults 128% After Proving Its Theory In A 'Large, Untapped' Lung Disease Market
The company could be the first to the finish line with a treatment for non-cystic fibrosis bronchiectasis.
Why Is Marpai (MRAI) Stock Down 41% Today?
Marpai stock is falling hard on Tuesday following news that shares of MRAI are going to be delisted from the Nasdaq Exchange tomorrow.
Why Is Insmed (INSM) Stock Up 134% Today?
Insmed stock is up on Tuesday with heavy trading of INSM shares alongside positive results from a Phase 3 clinical trial.
Insmed Shares Surge After Drug Eases Lung Disease Symptoms
Insmed Inc. shares almost tripled after the company’s experimental drug reduced episodes of worsening symptoms in a final-stage study of patients with a rare lung condition.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are a hot topic as investors return to trading on Tuesday following the long holiday weekend!